▟ Vinebot intrinsic value, daily

← back

CNC Centene Corporation

healthcare · valued with opus low conviction · deep-dived 2026-10-14

STRONG BUY
Intrinsic value$92.81
Price (at call)$68.86
Margin of safety +34.8%
vs market (rating basis) +70.1%

A Medicaid giant at trough margins; if repricing restores about 2.8%, the stock looks modestly undervalued.

The story

Centene is the largest US Medicaid managed-care and ACA Marketplace insurer, a scale, low-margin business whose edge is state contracting relationships and cost-of-care management rather than pricing power. After a 2025 reset driven by Marketplace risk-adjustment shortfalls, elevated Medicaid acuity following redeterminations, and Part D redesign, it is a mature company working through a cyclical margin trough. The repricing of rates and benefits should restore margins toward historical levels, while Marketplace membership shrinks as enhanced subsidies expire.

I set year-one growth flat because Marketplace attrition offsets Medicaid rate increases. Growth then settles at about 3.5% in a mature, government-funded market. The target margin of 2.8% matches Centene's pre-shock 2022-2024 range rather than any peak, and it takes about four years to get there as repricing catches up with acuity. Because the business is asset-light, sales-to-capital stays near 5. A 5% failure probability allows for regulatory and Medicaid-funding tail risk.

Value drivers

Revenue growth (Y1)0.0%
Terminal growth3.5%
Forecast horizon6y
Target operating margin2.8%
Years to target margin4
Sales-to-capital5.00
Beta0.90
Failure probability5.0%
Cost of capital (WACC)7.9%
Terminal WACC8.2%

Valuation bridge

PV of explicit FCFF8.31B
PV of terminal value39.65B
Equity value45.85B
÷ shares → per share$92.81

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 202.94B 0.0% -0.8% -1.23B 0 -1.23B -1.14B
2 204.36B 0.7% 0.4% 678.29M 284.11M 394.18M 338.41M
3 207.22B 1.4% 1.6% 2.64B 572.20M 2.06B 1.64B
4 211.57B 2.1% 2.8% 4.68B 870.32M 3.81B 2.81B
5 217.50B 2.8% 2.8% 4.81B 1.18B 3.63B 2.48B
6 225.11B 3.5% 2.8% 4.98B 1.52B 3.46B 2.19B

Key risks

  • Federal Medicaid funding cuts and work requirements reduce enrollment and squeeze state rates
  • Medicaid acuity and utilization keep outrunning rate increases, so margins stall below 2%
  • Marketplace morbidity worsens as healthier members leave after subsidies expire, causing further risk-adjustment shortfalls

Catalysts

  • 2026-2027 Medicaid rate cycles that reflect actual acuity
  • Marketplace repricing and membership shedding that restore a positive segment margin

History

DatePriceIntrinsicMoSRating
2026-10-14$68.86 $92.81 +34.8% STRONG BUY
2026-08-25$65.65 $0.00 -100.0% STRONG SELL
2026-07-03$67.86 $108.68 +60.2% STRONG BUY
2026-06-23$63.14 $110.76 +75.4% STRONG BUY